The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Sarcoma, Yoshida

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Sarcoma, Yoshida


High impact information on Sarcoma, Yoshida


Chemical compound and disease context of Sarcoma, Yoshida

  • Cathepsin L mRNA was also increased in tibialis anterior muscle of rats treated with the glucocorticoid analogue, dexamethasone, or rats bearing the Yoshida Sarcoma [11].
  • In a previous study, we used subcutaneous LY80 tumours (a subline of Yoshida sarcoma), Sato lung carcinoma, and methylcholanthrene-induced primary tumours, to demonstrate that a novel water-soluble combretastatin A-4 derivative, AC7700, abruptly and irreversibly stopped tumour blood flow [12].
  • CHIP was a more effective anti-tumour agent against both alkylating-agent sensitive and resistant strains of the Yoshida sarcoma (YSS and YSR respectively) than was Neoplatin [13].
  • The antitumor effect on Yoshida sarcoma was markedly potentiated when an additive dose of 5-FU combined with 3-cyano-2,6-dihydroxypyridine (CNDP), a potent inhibitor of 5-FU degradation, giving a plasma level of about 500 ng/ml, was infused for 4 h [14].
  • The antitumor effect of vincristine (VCR), which acts on mitotic phase cells, was examined with methionine infusion immediately after Met(-) TPN in Yoshida sarcoma (YS)-bearing rats [15].

Biological context of Sarcoma, Yoshida


Anatomical context of Sarcoma, Yoshida


Gene context of Sarcoma, Yoshida


Analytical, diagnostic and therapeutic context of Sarcoma, Yoshida


  1. Molecular transformation of tumor adenylosuccinate synthetase and characteristics of its converting factor. Matsuda, Y., Shiraki, H., Nakagawa, H. Cancer Res. (1982) [Pubmed]
  2. Two forms of thymidine kinase in normal and tumor tissues of animals. Ohash, I.M., Taguchi, T. Cancer Res. (1976) [Pubmed]
  3. Effect of hyperglycemia on blood flow, pH, and response to hyperthermia (42 degrees) of the Yoshida sarcoma in the rat. Calderwood, S.K., Dickson, J.A. Cancer Res. (1980) [Pubmed]
  4. Antitumor activity of BOF-A2, a new 5-fluorouracil derivative. Fujii, S., Fukushima, M., Shimamoto, Y., Ohshimo, H., Imaoka, T., Shirasaka, T. Jpn. J. Cancer Res. (1989) [Pubmed]
  5. Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides. Peter, G., Hohorst, H.J. Cancer Chemother. Pharmacol. (1979) [Pubmed]
  6. Collateral sensitivity between methylene dimethane sulfonate and halogenated methotrexate derivatives in the Yoshida sarcoma in vivo and in vitro. Fox, B.W. J. Natl. Cancer Inst. (1977) [Pubmed]
  7. Kinetics of the acute-phase reaction in rats after tumor transplantation. Abd-el-Fattah, M., Scherer, R., Fouad, F.M., Ruhenstroth-Bauer, G. Cancer Res. (1981) [Pubmed]
  8. A new deoxyuridine-5'-triphosphatase in Yoshida sarcoma cells involved in deoxyuridine 5'-triphosphate metabolism. Arima, T., Akiyoshi, H., Fujii, S. Cancer Res. (1977) [Pubmed]
  9. Characterization of pyrimidine nucleoside monophosphokinase in normal and malignant tissues. Arima, T., Akiyoshi, H., Fujii, S. Cancer Res. (1977) [Pubmed]
  10. Nucleotide and deduced amino acid sequences of two distinct cDNAs for rat phosphoribosylpyrophosphate synthetase. Taira, M., Ishijima, S., Kita, K., Yamada, K., Iizasa, T., Tatibana, M. J. Biol. Chem. (1987) [Pubmed]
  11. Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting. Deval, C., Mordier, S., Obled, C., Bechet, D., Combaret, L., Attaix, D., Ferrara, M. Biochem. J. (2001) [Pubmed]
  12. A novel combretastatin A-4 derivative, AC7700, strongly stanches tumour blood flow and inhibits growth of tumours developing in various tissues and organs. Hori, K., Saito, S., Kubota, K. Br. J. Cancer (2002) [Pubmed]
  13. Criteria for the selection of second-generation platinum compounds. Shepherd, R., Kusnierczyk, H., Jones, M., Harrap, K.R. Br. J. Cancer (1980) [Pubmed]
  14. Pharmacokinetic modulation of plasma 5-fluorouracil concentrations to potentiate the antitumor activity of continuous venous infusion of 5-fluorouracil. Fujii, S., Fukushima, M., Shimamoto, Y., Shirasaka, T. Jpn. J. Cancer Res. (1989) [Pubmed]
  15. Enhanced anticancer effect of vincristine with methionine infusion after methionine-depleting total parenteral nutrition in tumor-bearing rats. Goseki, N., Nagahama, T., Maruyama, M., Endo, M. Jpn. J. Cancer Res. (1996) [Pubmed]
  16. Evidence for peroxidative oxidation of substituted piperidine nitroxides, acting as apoptosis inducers in Yoshida Sarcoma cells in vivo. Metodiewa, D., Kochman, A., Gebicka, L., Skolimowski, J. Anticancer Res. (2000) [Pubmed]
  17. Metabolic effects of medium chain triglyceride-enriched total parenteral nutrition in rats bearing Yoshida sarcoma. Swenson, E.S., Crosby, L.E., Babayan, V.K., Blackburn, G.L., Bistrian, B.R. J. Nutr. Biochem. (1990) [Pubmed]
  18. The possible role of stromal influences in tumor cell heterogeneity. Histology and fibronectin pattern of the Yoshida sarcoma of the rat. Jiwa, M., Van den Hooff, A. Anticancer Res. (1985) [Pubmed]
  19. Effect of uracil on metabolism of 5-fluorouracil in vitro. Ikenaka, K., Shirasaka, T., Kitano, S., Fujii, S. Gann = Gan. (1979) [Pubmed]
  20. Tumor-selective blood flow decrease induced by an angiotensin converting enzyme inhibitor, temocapril hydrochloride. Hori, K., Saito, S., Takahashi, H., Sato, H., Maeda, H., Sato, Y. Jpn. J. Cancer Res. (2000) [Pubmed]
  21. Effects of intravenous infusion of dopamine on tumor blood flow in rat subcutis. Tanda, S., Hori, K., Saito, S., Zhang, Q.H., Li, H.C., Suzuki, M. Jpn. J. Cancer Res. (1994) [Pubmed]
  22. A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro. McGown, A.T., Fox, B.W. Cancer Chemother. Pharmacol. (1986) [Pubmed]
  23. Alpha-Fetoprotein synthesis in cultured cells: studies on Yoshida sarcoma and ascites hepatoma in vitro. Isaka, H., Umehara, S., Tsukada, Y. Ann. N. Y. Acad. Sci. (1975) [Pubmed]
  24. Cartilage-degrading neutral proteinase secreted by Yoshida sarcoma cells. Purification and properties. Mikuni-Takagaki, Y., Gross, J. J. Biol. Chem. (1984) [Pubmed]
  25. Schedule dependent inhibition of thymidylate synthase and tumor growth by 5-fluorouracil in Yoshida sarcoma bearing rats. Tsujinaka, T., Kido, Y., Shiozaki, H., Mori, T. Journal of surgical oncology. (1992) [Pubmed]
  26. Intracellular distribution of various enzymes concerned with DNA synthesis from normal and regenerating rat liver, and Yoshida sarcoma. Shiosaka, T., Arima, T., Toide, H., Okuda, H., Fujii, S. J. Biochem. (1975) [Pubmed]
  27. Tumor-derived components were responsible for suppression of ornithine decarboxylase activity in the rat wounded skin. Abe, Y., Imamura, K., Ogawa, Y., Tsujinaka, T., Kobayashi, M., Yano, M., Kido, Y., Tanaka, T., Mori, T. Journal of surgical oncology. (1994) [Pubmed]
  28. Synthesis and collagenase inhibition of new glycosides of aranciamycinone: the aglycon of the naturally occurring antibiotic aranciamycin. Bols, M., Binderup, L., Hansen, J., Rasmussen, P. Carbohydr. Res. (1992) [Pubmed]
  29. Effect of structured lipid-enriched total parenteral nutrition in rats bearing yoshida sarcoma. Crosby, L.E., Swenson, E.S., Babayan, V.K., Blackburn, G.L., Bistrian, B.R. J. Nutr. Biochem. (1990) [Pubmed]
  30. The interaction of dianhydrogalactitol with DNA in cultured Yoshida sarcoma cells. Institoris, E., Fox, B.W. Chem. Biol. Interact. (1978) [Pubmed]
  31. Purification and characterization of GMP synthetase from Yoshida sarcoma ascites cells. Hirai, K., Matsuda, Y., Nakagawa, H. J. Biochem. (1987) [Pubmed]
  32. IMP dehydrogenase. I. Studies on regulatory properties of crude tissue extracts based on an improved assay method. Shimura, K., Okada, M., Shiraki, H., Nakagawa, H. J. Biochem. (1983) [Pubmed]
  33. Further studies on the cytochemistry of the standardized silver staining of interphase nucleoli in smear preparations of Yoshida ascitic sarcoma cells in rats. Likovský, Z., Smetana, K. Histochemistry (1981) [Pubmed]
WikiGenes - Universities